About Valneva SE (VALN)
Valneva is a biotechnology company. The Company focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva serves customers in France.
- 12.58
- 13.53
- 12.58
- 6.72k
Stock News
1 hour ago
Key Words: Reed Hastings admits Netflix should have added commercials years ago
MarketWatch
1 hour ago
MarketWatch First Take: Salesforce better get used to Marc Benioff in charge, because he keeps chasing off his chosen successors
MarketWatch
2 hours ago
Petrobras boosts its five-year investment plan to $78 billion
Reuters
2 hours ago
New York, Singapore top world's costliest city list...
Bloomberg
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
